Homeostasis model assessment to detect insulin resistance and identify patients at high risk of breast cancer development: National Cancer Institute of Naples experience

[1]  Dong Jun Kim.  Summary of the American Diabetes Association Standards of Medical Care in Diabetes 2012 , 2012 .

[2]  V. Basevi,et al.  Standards of Medical Care in Diabetes—2012 , 2011, Diabetes Care.

[3]  B. Spiegelman,et al.  Molecular mechanisms of cancer development in obesity , 2011, Nature Reviews Cancer.

[4]  J. Reynolds,et al.  Visceral obesity, metabolic syndrome, insulin resistance and cancer , 2011, Proceedings of the Nutrition Society.

[5]  M. S. Kirkman,et al.  Response to Comment on: American Diabetes Association. Standards of Medical Care in Diabetes—2011. Diabetes Care 2011;34(Suppl. 1):S11–S61 , 2011, Diabetes Care.

[6]  E. Lee,et al.  Adipokines, insulin resistance, metabolic syndrome, and breast cancer recurrence: a cohort study , 2011, Breast Cancer Research.

[7]  A. Vecchione,et al.  Metabolic syndrome affects breast cancer risk in postmenopausal women: National Cancer Institute of Naples experience , 2010, Cancer biology & therapy.

[8]  D. Harlan,et al.  Diabetes and Cancer , 2010, Diabetes Care.

[9]  R Bethene Ervin,et al.  Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: United States, 2003-2006. , 2009, National health statistics reports.

[10]  Jane B Shofer,et al.  Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. , 2004, Diabetes.

[11]  H. Chew.  Clinical breast cancer and estrogen , 2003, Breast Cancer Research.

[12]  JoAnn E Manson,et al.  Type 2 diabetes and subsequent incidence of breast cancer in the Nurses' Health Study. , 2003, Diabetes care.

[13]  C. Rotimi,et al.  Waist–hip ratio and breast cancer risk in urbanized Nigerian women , 2002, Breast Cancer Research.

[14]  B. Stoll.  Upper abdominal obesity, insulin resistance and breast cancer risk , 2002, International Journal of Obesity.

[15]  C. Friedenreich,et al.  Case‐control study of anthropometric measures and prostate cancer risk , 2002, International journal of cancer.

[16]  Rudolf Kaaks.  Plasma insuline, IGF-I et cancer du sein , 2001 .

[17]  B. Stoll.  Western nutrition and the insulin resistance syndrome: A link to breast cancer , 1999, European Journal of Clinical Nutrition.

[18]  David J Hunter,et al.  Circulating concentrations of insulin-like growth factor I and risk of breast cancer , 1998, The Lancet.

[19]  S. Tretli,et al.  Dietary fat and the risk of breast cancer: A prospective study of 25,892 Norwegian women , 1995, International journal of cancer.

[20]  R. Brand,et al.  Elevated insulin receptor content in human breast cancer. , 1990, The Journal of clinical investigation.

[21]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[22]  F. Berrino,et al.  Metabolic syndrome and postmenopausal breast cancer in the ORDET cohort: a nested case-control study. , 2010, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[23]  C. Friedenreich,et al.  Case‐control study of anthropometric measures and breast cancer risk , 2002, International journal of cancer.

[24]  R. Kaaks.  [Plasma insulin, IGF-I and breast cancer]. , 2001, Gynecologie, obstetrique & fertilite.

[25]  H. Grosse.  [Diabetes and cancer]. , 1956, Deutsche Zeitschrift fur Verdauungs- und Stoffwechselkrankheiten.